Roche MagNA Pure 24 & 96 Supplies

The Florida Department of Health (DOH) Bureau of Public Health Laboratories (BPHL) is seeking to procure Roche MagNA Pure 24 & 96 supplies through a single-source procurement process. This solicitation, identified as State Local Contract Opportunity ID 6717cf867ab6897cd90915c2, is specific to Leon County and focuses on chemical evaluation instruments and supplies for existing Roche MagNA Pure LC 2.0 and MagNA Pure Compact instruments. The primary objective is to support public health emergency preparedness activities, including pandemic influenza and Laboratory Response Network (LRN) methods for detecting bioterrorism threat agents and emerging infectious diseases. The procurement is justified by the CDC's validation and approval of Roche supplies, which are critical for maintaining quick turnaround times in public health testing. The contract opportunity was posted on October 22, 2024, with proposals due by November 13, 2024, in accordance with Chapter 60A-1.045 of the Florida Administrative Code. The DOH BPHL requires these supplies to ensure continuous and efficient testing processes for critical public health initiatives.

The procurement is a single-source acquisition directly with Roche Diagnostics Corporation, who is identified as the exclusive manufacturer and distributor of the required MagNA Pure 24 & 96 supplies. No specific set-aside designations or restrictions on responding organizations are mentioned in the documentation. The existing infrastructure consists of Roche MagNA Pure LC 2.0 and MagNA Pure Compact instruments, which will be supported by these new supplies. The estimated budget for this three-year procurement is $450,000, representing a significant investment in maintaining the state's public health laboratory capabilities. The contract appears to be specifically tailored to the DOH BPHL's needs, with no indication of alternative vendors or competitive bidding. Roche's supplies have been strategically chosen based on their ability to extract the required number of samples within necessary short turnaround times, demonstrating a targeted approach to meeting the department's critical testing requirements.